Filing excerpt
Research and development expenses decreased $21.1 million, or 26.1%, for the three months ended December 27, 2025, compared to the three months ended December 28, 2024. This decrease was primarily due to ongoing savings resulting from our cost transformation initiatives, including lower personnel-related costs due to lower headcount, and lower product development costs.